<div id="subtitle">Bristol-Myers Squibb spent $953,000 lobbying on drug pricing, health overhaul in third quarter</div><div><p>Pharmaceutical company Bristol-Myers Squibb Co. spent $953,000 lobbying on drug pricing and access, health care and patent reform in the third quarter, according to a quarterly disclosure form.</p&gt ...

<div id="subtitle">Bristol-Myers Squibb cuts 2009 profit outlook following Mead Johnson holdings split</div><div><p>Drug developer Bristol-Myers Squibb Co. cut its 2009 profit outlook Wednesday after completing a split off of its Mead Johnson Nutrition Co. holdings.</p><p>The company now expects adjusted profit ...

<div id="subtitle">Bristol-Myers lifts dividend to 32 cents from 31 cents, dividend is payable paid Feb. 1</div><div><p>Drugmaker Bristol-Myers Squibb Co. said Monday it raised its quarterly dividend by a penny, to 32 cents from 31 cents.</p><p>The dividend is payable Feb ...

<div id="subtitle">Bristol-Myers Squibb says Mead Johnson stock offer was oversubscribed</div><div><p>Drugmaker Bristol-Myers Squibb Co. said Friday its offer to exchange shares of baby formula maker Mead Johnson Nutrition Co. for shares of its own stock was oversubscribed.</p><p>The company said it ...